STRO 2.67 (-1.11%)
US8693671021BiotechnologyBiotechnology

Sutro Biopharma (STRO) Financial Metrics

This table shows a selected set of financial data points of Sutro Biopharma (STRO). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -1.78 0 -2.42 258.1M -0.24 153.73M -115.93M -67.95M -106.79M 69.27M
2022 -2.35 0 -3.44 409.97M -0.32 67.77M -4.31M -119.8M -119.2M 47.25M
2021 -2.29 0 -6.5 686.25M -0.29 61.88M -97M -93.1M -105.54M 30.41M
2020 -0.99 0 -22.01 707.17M -0.12 42.72M -74.93M -65.25M -32.13M 206.15M
2019 -2.43 0 -4.53 252.54M -0.29 42.74M -68.5M -46.62M -55.74M 4.96M
2018 -6.13 0 -1.47 51.95M -0.27 38.42M 11.13M -29.16M -35.32M 125.3M
2017 -3.57 0 0 0 -0.36 51.74M -40.39M -14.09M -19.69M 22.02M
2016 0.24 0 0 0 0 59.73M -17.55M 7.36M 1.7M 11.59M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.